NPS MedicineWise Update
NPS MedicineWise, of which the AMA is a member, has recently announced a new Statins: optimising therapy, addressing intolerance educational program, which launched in June this year. Readings and resources for GPs have been made available on the NPS MedicineWise website.
Statins are a foundation of lipid management due to their well-established efficacy at preventing vascular events. Despite this proven efficacy and safety, use of statins in clinical practice, and adherence to these medicines by patients, is not optimal.
![](/sites/default/files/styles/limit_height/public/documents/Medical_Student.jpg?itok=jiFQ7PDw)
NPS MedicineWise program is designed to reinforce the role of absolute cardiovascular risk assessment, the optimal use of statin therapy and provides tools and resources to address suspected statin-associated muscle symptoms.
The following products have been released:
- An accredited educational visiting program: Statins: optimising therapy, addressing intolerance
- Online and interactive case study tailored by audience to GPs, pharmacists and nurses: Interactive case study: Optimising statin therapy
- Reading for GPs, nurses and pharmacists: MedicineWise News: Uncovering the truth about statin intolerance
- Resources for GPs, nurses and pharmacists: SAMS Assessment Guide & Management Algorithm
- Resource for GPs: Patient Action Plan: Assessing and managing muscle symptoms in people taking statins
- Resource for consumers: Statin medicines FAQ factsheet
For more information please contact: Catherine Pitre on (02) 8217 9238 or CPitre@nps.org.au.